• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High-PEEP Noninvasive Ventilation By Means of Mask as the Respiratory Support in COVID-19 ARDS Patients: Experience From General Hospital Slavonski Brod.高呼气末正压无创通气通过面罩作为 COVID-19 急性呼吸窘迫综合征患者的呼吸支持:来自斯拉沃尼亚布罗德综合医院的经验。
Disaster Med Public Health Prep. 2022 May 2;17:e151. doi: 10.1017/dmp.2022.102.
2
Breathing pattern, accessory respiratory muscles work, and gas exchange evaluation for prediction of NIV failure in moderate-to-severe COVID-19-associated ARDS after deterioration of respiratory failure outside ICU: the COVID-NIV observational study.呼吸模式、辅助呼吸肌做功和气体交换评估对 ICU 外呼吸衰竭恶化后中重度 COVID-19 相关 ARDS 患者行 NIV 治疗失败的预测作用:COVID-NIV 观察性研究。
BMC Anesthesiol. 2022 Oct 1;22(1):307. doi: 10.1186/s12871-022-01847-7.
3
Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients.在高流量氧疗或无创通气期间急性呼吸窘迫综合征标准的局限性:来自危重症 COVID-19 患者的证据。
Crit Care. 2022 Mar 7;26(1):55. doi: 10.1186/s13054-022-03933-1.
4
Efficacy and Safety of High PEEP NIV in COVID-19 Patients.高呼气末正压无创通气在新冠病毒肺炎患者中的疗效与安全性
Disaster Med Public Health Prep. 2024 May 30;18:e97. doi: 10.1017/dmp.2024.85.
5
Timing and Outcomes of Noninvasive Ventilation in 307 ARDS COVID-19 Patients: An Observational Study in an Italian Third Level COVID-19 Hospital.307 例 COVID-19 相关 ARDS 患者应用无创通气的时机和结局:意大利三级 COVID-19 医院的一项观察性研究。
Medicina (Kaunas). 2022 Aug 15;58(8):1104. doi: 10.3390/medicina58081104.
6
Implications of early respiratory support strategies on disease progression in critical COVID-19: a matched subanalysis of the prospective RISC-19-ICU cohort.早期呼吸支持策略对危重新冠肺炎疾病进展的影响:前瞻性 RISC-19-ICU 队列的匹配亚组分析。
Crit Care. 2021 May 25;25(1):175. doi: 10.1186/s13054-021-03580-y.
7
Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors.急性低氧性呼吸衰竭的无创通气:插管率及危险因素
Crit Care. 2013 Nov 11;17(6):R269. doi: 10.1186/cc13103.
8
[Study of timing of invasive and noninvasive sequential ventilation in patients with acute respiratory distress syndrome].[急性呼吸窘迫综合征患者有创与无创序贯通气时机的研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 May;26(5):330-4. doi: 10.3760/cma.j.issn.2095-4352.2014.05.009.
9
High-Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in Patients with COVID-19.高流量鼻氧疗治疗严重低氧血症:COVID-19 患者的氧合反应和结局。
Am J Respir Crit Care Med. 2022 Feb 15;205(4):431-439. doi: 10.1164/rccm.202109-2163OC.
10
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial.新冠肺炎合并中重度低氧血症呼吸衰竭患者使用头盔无创通气与高流量鼻导管吸氧治疗后脱机时间的影响:HENIVOT 随机临床试验
JAMA. 2021 May 4;325(17):1731-1743. doi: 10.1001/jama.2021.4682.

引用本文的文献

1
Low versus high positive end expiratory pressure in noninvasive ventilation for hypoxemic respiratory failure: a multicenter randomized controlled trial.低呼气末正压与高呼气末正压用于低氧血症性呼吸衰竭无创通气的多中心随机对照试验
Intensive Care Med. 2025 Apr 30. doi: 10.1007/s00134-025-07902-4.
2
CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study.持续气道正压通气与高流量鼻导管吸氧治疗新型冠状病毒肺炎急性呼吸窘迫综合征患者的回顾性倾向匹配研究
Can J Respir Ther. 2024 Oct 31;60:164-172. doi: 10.29390/001c.125145. eCollection 2024.

高呼气末正压无创通气通过面罩作为 COVID-19 急性呼吸窘迫综合征患者的呼吸支持:来自斯拉沃尼亚布罗德综合医院的经验。

High-PEEP Noninvasive Ventilation By Means of Mask as the Respiratory Support in COVID-19 ARDS Patients: Experience From General Hospital Slavonski Brod.

机构信息

Department of Anesthesiology and Intensive Medicine, General Hospital Dr Josip Benčević, Slavonski Brod, Croatia.

出版信息

Disaster Med Public Health Prep. 2022 May 2;17:e151. doi: 10.1017/dmp.2022.102.

DOI:10.1017/dmp.2022.102
PMID:35492009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9203416/
Abstract

OBJECTIVE

Despite widespread use of noninvasive ventilation (NIV) in some coronavirus disease 2019 (COVID-19) hypoxemic patients, its clinical application is still subject of debate.

METHODS

This is a retrospective, observational study with data collected from 91 consecutive patients treated in COVID intensive care unit (ICU) in our institution between October 2020 and February 2021. Outcomes were represented as ventilation hours, ICU and hospital length of stay, and ICU and hospital mortality.

RESULTS

Patients' mean age was 66 ± 11 y and severe COVID-19 pneumonia with mean paO/FiO 137 ± 57 was observed in 90% of the patients. High positive end-expiratory pressure (PEEP) NIV by means of total face mask was initially applied in 58 (64%) patients, high flow oxygen therapy (HFOT) in 25 (27%) patients, whilst invasive mechanical ventilation (IMV) started at the moment of admission in 8 (9%) patients. NIV and high flow oxygen therapy (HFOT) have been kept on throughout ICU stay in 50 (55%) patients, while 41 (45%) patients were put on IMV. Overall ICU mortality was 41%, while ICU mortality of patients on NIV was 14%.

CONCLUSIONS

High PEEP NIV was convenient and safe as initial respiratory support and in some COVID-19 ARDS patients remained an optimal respiratory support throughout their disease.

摘要

目的

尽管在一些 COVID-19 低氧血症患者中广泛应用无创通气(NIV),但其临床应用仍存在争议。

方法

这是一项回顾性观察性研究,数据来自 2020 年 10 月至 2021 年 2 月期间我院 COVID-19 重症监护病房(ICU)连续收治的 91 例患者。结果表示为通气时间、ICU 和住院时间以及 ICU 和住院死亡率。

结果

患者平均年龄为 66 ± 11 岁,90%的患者患有严重 COVID-19 肺炎,平均 paO/FiO 为 137 ± 57。最初有 58 例(64%)患者采用全面罩高正压通气(NIV),25 例(27%)患者采用高流量氧疗(HFOT),8 例(9%)患者入院时即开始有创机械通气(IMV)。50 例(55%)患者在 ICU 期间持续接受 NIV 和 HFOT,41 例(45%)患者接受 IMV。总的 ICU 死亡率为 41%,而接受 NIV 的患者的 ICU 死亡率为 14%。

结论

高 PEEP NIV 作为初始呼吸支持方便且安全,在一些 COVID-19 急性呼吸窘迫综合征患者中,在整个疾病过程中仍然是一种最佳的呼吸支持。